Ingenia Therapeutics Inc. (KOSDAQ:950260)

Ingenia Therapeutics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Net Income	-26,810	-26,448	21,458
Depreciation & Amortization	1,085	1,041	305.18
Loss (Gain) From Sale of Assets	-	-	1.08
Loss (Gain) From Sale of Investments	-4,104	-4,676	-43,807
Stock-Based Compensation	1,515	1,252	898.97
Other Operating Activities	-4,757	-4,518	4,194
Change in Accounts Receivable	-15.8	717.45	-735
Change in Other Net Operating Assets	229.28	1,369	-2,092
Operating Cash Flow	-32,858	-31,262	-19,777
Operating Cash Flow Growth	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Capital Expenditures	-954.2	-780.1	-278.61
Sale of Property, Plant & Equipment	-	-	0.99
Sale (Purchase) of Intangibles	-	-	-220.5
Investment in Securities	34,115	36,542	3,605
Other Investing Activities	-53.79	78.35	-311.56
Investing Cash Flow	33,107	35,840	2,795

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Long-Term Debt Repaid	-	-762.59	-
Net Debt Issued (Repaid)	-792.34	-762.59	-
Issuance of Common Stock	797.2	808.75	612.23
Financing Cash Flow	4.86	46.16	15,312

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Foreign Exchange Rate Adjustments	1	-7.2	-0.65
Miscellaneous Cash Flow Adjustments	-	0	-
Net Cash Flow	255.43	4,617	-1,670

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Free Cash Flow	-33,812	-32,042	-20,056
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	-	-	-568.06%
Free Cash Flow Per Share	-1626.18	-2360.00	-472.00
Levered Free Cash Flow	-	-20,992	-
Unlevered Free Cash Flow	-	-20,880	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Cash Interest Paid	163.77	178.38	-
Cash Income Tax Paid	2,127	2,068	6,814
Change in Working Capital	213.48	2,087	-2,827

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error